Incidence of post-transfusion hepatitis in Taiwan before and after introduction of anti-HCV testing

Liver

Volumn 16, Issue 3, 1996, Pages 201-206

  Chang, Ting Tsung ^a,b   Young, Kung Chia ^a   Yang, Yu Jen ^a   Lai, Kuo An ^a   Wu, Hua Lin ^a   Wu, Mingo Ho ^a   Chen, Mao Yuan ^b   Lin, Xi Zhang ^a   Lin, Ching Yih ^a   Shin, Jeng Shiann ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti HCV; Donor screening; Post transfusion hepatitis; Type C hepatitis

Indexed keywords

HEPATITIS ANTIBODY; VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS NON A NON B; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NONHUMAN; POLYMERASE CHAIN REACTION; SCREENING; TAIWAN; VIREMIA; VIRUS DETECTION;

EID: 9444291296     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0676.1996.tb00728.x     Document Type: Article

References (36)

1. SEEFF LB, ZIMMERMAN HJ, WRIGHT EC, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study. Gastroenterology 1977: 72: 111-121.
2. AACH RD, KAHN RA. Post-transfusion hepatitis: current perspectives. Ann Intern Med 1980: 92: 539-546.
3. FEINMAN SV, BERRIS B, BOJARSKI S. Post-transfusion hepatitis in Toronto, Canada. Gastroenterology 1988: 95: 464-469.
4. KNODELL RG, CONRAD ME, DIENSTAG JL, BELL CJ. Etiological spectrum of post-transfusion hepatitis. Gastroenterology 1975: 69: 1278-1285.
5. BRADLEY DW, MAYNARD JE, POPPER H, et al. Post-transfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis 1983: 148: 254-265.
6. AZAR N, VALLA D, LUNEL F, et al. Post-transfusional anti-HCV-negative, non-A, non-B hepatitis. (I) A prospective clinical and epidemiological survey. J Hepatol 1993: 18: 24-33.
7. PETERS T, SCHLAYER HJ, PREISLER S, et al. Frequency of hepatitis C in acute post-transfusion hepatitis after open-heart surgery: a prospective study in 1476 patients. J Med Virol 1993: 39: 139-145.
8. KORETZ RL, SUFFIN SC, GITNICK GL. Post-transfusion chronic liver disease. Gastroenterology 1976: 71: 797-803.
9. BERMAN M, ALTER HJ, ISHAK KG, PURCELL RH, JONES EA. The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 1979: 91: 1-6.
10. CHOO QL, KUO G, WEINER AJ, OVERBY LR, BRADLEY DW, HOUGHTON M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989: 244: 359-362.
11. KUO G, CHOO QL, ALTER HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989: 244: 362-364.
12. ESTEBAN JI, GONZALEZ A, HERNANDEZ JM, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990: 323: 1107-1112.
13. VAN DER POEL CL, REESINK HW, SCHAASBERG W, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990: 335: 558-560.
14. AACH RD, STEVENS CE, HOLLINGER FB, et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991: 325: 1325-1329.
15. FEINMAN SV, BERRIS B, HERST R. Anti-HCV in post-transfusion hepatitis: deductions from a prospective study. J Hepatol 1991: 12: 377-381.
16. TREMOLADA F, CASARIN C, TAGGER A, et al. Antibody to hepatitis C virus in post-transfusion hepatitis. Ann Intern Med 1991: 114: 277-281.
17. LIOU TC, CHANG TT, YOUNG KC, LIN XZ, LIN CY, WU HL. Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. J Med Virol 1992: 37: 197-202.
18. YOUNG KC, CHANG TT, LIOU TC, WU HL. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and saliva. J Med Virol 1993: 41: 55-60.
19. OKAMOTO H, OKADA S, SUGIYAMA Y, et al. Detection with two pairs of primers deduced from the 5′ non-coding region. Jpn J Exp Med 1990: 60: 215-222.
20. PAO CC, YAO DS, LIN CY, et al. Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function. Clin Microbiol Clin Chem 1991: 95: 591-596.
21. ALTER HJ, PURCELL RH, SHIH JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, nonB hepatitis. N Engl J Med 1989: 321: 1494-1500.
22. LEE SD, TSAI YT, HUANG SJ, et al. A prospective study of post-transfusion non-A, non-B (type C) hepatitis following cardiovascular surgery in Taiwan. J Med Virol 1991: 33: 188-192.
23. WANG TH, WANG JT, LIN JT, SHEU JC, SUNG JL, CHEN DS. A prospective study of post-transfusion hepatitis in Taiwan. J Hepatol 1991: 13: 38-43.
24. ALTER HJ. Descartes before the horse: I clone, therefore I am: the hepatitis C virus in current perspective. Ann Intern Med 1991: 115: 644-649.
25. DONAHUE JG, MUNOZ A, NESS PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992: 327: 369-373.
26. TAKANO S, OMATA M, OHTO M, SATOMURA Y. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing post-transfusion hepatitis. Hepatology 1993: 18: 235-239.
27. CONRAD ME, KNODELL RG, BRADLEY EL, FLANNERY EP, GINSBERG AL. Risk, factors in transmission of non-A, non-B post-transfusion hepatitis. Transfusion 1977: 17: 579-585.
28. TAKANO S, OMATA M, OHTO M, SATOMURA Y. Post-transfusion hepatitis in Japan. Vox Sang 1992: 62: 156-164.
29. VILLA E, FERRETTI I, DEPALMA M, et al. HCV-RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH). J Hepatol 1991: 13: 256-259.
30. KATO N, YOKOSUKA O, OMATA M, HOSODA K, OHTO M. Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction. J Clin Invest 1990: 86: 1764-1767.
31. JAPANESE RED CROSS NON-A, NON-B HEPATITIS RESEARCH GROUP. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991: 338: 1040-1041.
32. LUGASSY C, BERNUAU J, THIERS V, et al. Hepatitis B virus DNA sequences in the serum and liver of patients with acute benign and fulminant hepatitis. J Infect Dis 1987: 155: 64-71.
33. LIANG TJ, ISELBACHER KJ, WANDS RJ. Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest 1989: 84: 1367-1371.
34. TSIQUAYE KN, BIRD RG, TOVEY G, WYKE RJ, WILLIAMS R. Further evidence for two agents of non-A, non-B hepatitis in experimentally infected chimpanzees. J Med Virol 1980: 5: 63-71.
35. KORETZ RL, BREZINA M, POLITO AJ, et al. Non-A, non-B post-transfusion hepatitis: comparing C and non-C hepatitis. Hepatology 1993: 17: 361-365.
36. PETERS T, MOHR L, SCHEIFFELE F, et al. Antibodies and viremia in acute post-transfusion hepatitis C: a prospective study. J Med Virol 1994: 42: 420-427.